Hunting for protective drugs at the break of a pandemic: Causal inference from hospital data. (September 2022)

• Record Type: Journal Article
• Authors: Berzuini, Carlo; Bernardinelli, Luisa
• Other Names: De Angelis Daniela guest-editor.; Birrell Paul guest-editor.; Funk Sebastian guest-editor.; House Thomas guest-editor.
• Is Part Of: Statistical methods in medical research. Volume 31:Number 9(2022)
• Page Start: 1803
• Page End: 1816
• Publication Date: 2022-09
• Subjects: Observational studies -- causal graphical models -- conditional independence -- causal inference -- propensity score -- matching -- mechanistic interaction -- effect modifier -- hospital data -- renin Aldosterone System inhibitors -- severe acute respiratory syndrome coronavirus 2 -- Covid-19 -- hypertension -- angiotensin-converting enzyme inhibitor -- angiotensin receptor blocker; Medicine -- Research -- Statistical methods -- Periodicals; Research -- Periodicals; Review Literature -- Periodicals; Statistics -- methods -- Periodicals; Médecine -- Recherche -- Méthodes statistiques -- Périodiques; 610.727
• DOI: 10.1177/09622802221098428
• Languages: English
• ISSNs: 0962-2802

Abstract

At the break of a pandemic, the protective efficacy of therapeutic interventions needs rapid evaluation. An experimental approach to the problem will not always be appropriate. An alternative route are observational studies, whether based on regional health service data or hospital records. In this paper, we discuss the use of methods of causal inference for the analysis of such data, with special reference to causal questions that may arise in a pandemic. We apply the methods by using the aid of a directed acyclic graph (DAG) representation of the problem, to encode our causal assumptions and to logically connect the scientific questions. We illustrate the usefulness of DAGs in the context of a controversy over the effects of renin aldosterone system inhibitors (RASIs) in hypertensive individuals at risk of (or affected by) severe acute respiratory syndrome coronavirus 2 disease. We consider questions concerning the existence and the directions of those effects, their underlying mechanisms, and the possible dependence of the effects on context variables. This paper describes the cognitive steps that led to a DAG representation of the problem, based on background knowledge and evidence from past studies, and the use of the DAG to analyze our hospital data and assess the interpretive limits of the results. Our study contributed to subverting early opinions about RASIs, by suggesting that these drugs may indeed protect the older hypertensive Covid-19 patients from the consequences of the disease. Mechanistic interaction methods revealed that the benefit may be greater (in a sense to be made clear) in the older stratum of the population.